STAGE IVA UTERINE CORPUS CANCER AJCC V8
Clinical trials for STAGE IVA UTERINE CORPUS CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA UTERINE CORPUS CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA UTERINE CORPUS CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Chemo mist shows promise for Hard-to-Treat abdominal cancers
Disease control Recruiting nowThis early-stage study tests a procedure called PIPAC that turns liquid chemotherapy into a fine mist and sprays it directly into the abdomen during a minimally invasive surgery. It is for people with ovarian, uterine, appendix, colorectal, or stomach cancer that has spread to th…
Matched conditions: STAGE IVA UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 14:17 UTC
-
Electric field device joins drug combo to fight advanced cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to see i…
Matched conditions: STAGE IVA UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Custom-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system attack cancer more effectively. …
Matched conditions: STAGE IVA UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
New drug combo trial aims to tame advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, alone or with other medicines, in people with advanced solid tumors (like melanoma, ovarian, or head and neck cancers) that have not responded to standard treatments. The main goal is to find the safest dose and understand…
Matched conditions: STAGE IVA UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC